Trends in Primary Antibiotic Resistance in H. pylori Strains Isolated in Italy between 2009 and 2019
Ilaria Maria Saracino, Giulia Fiorini, Angelo Zullo and 3 more
Antibiotics · 2020
doi:10.3390/antibiotics9010026 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Background and aims: the increasing prevalence of strains resistant to antimicrobial agents is a critical issue for the management of <i>Helicobacter pylori</i> infection. This study aimed to evaluate, in Italian naïve patients, <i>H. pylori</i> antibiotic resistance trends and their potential predictive factors during the last decade. Methods: consecutive Italian naïve <i>H. pylori</i> positive patients, referred from General Practitioners to our Unit from January 2009 to January 2019 to perform an upper gastrointestinal endoscopy (UGIE), were considered. Each patient underwent <sup>13</sup>C-urea breath test (<sup>13</sup>C-UBT) and UGIE with multiple biopsies to perform rapid urease test (RUT), culture/susceptibility test (vs. clarithromycin, metronidazole, levofloxacin), and histopathological examination. <i>H. pylori</i> status was assessed through CRM (composite reference method: at least two tests positive or only culture positive). Results: between 2009 and 2014, 1763 patients were diagnosed as <i>H. pylori</i> positive, 907 were naïve with antibiogram available. Between 2015 and 2019, 1415 patients were diagnosed as <i>H. pylori</i> positive, antibiotic susceptibility test was available in 739 naïve patients. <i>H. pylori</i> primary antibiotic resistance rates in the first and second five-year period were, respectively, clarithromycin 30.2% (95% CI 27.2−33.3), 37.8% (95% CI 34.2−41.4); metronidazole 33.3% (95% CI 30.2−36.5), 33.6% (95% CI 30.2−37.1); levofloxacin 25.6% (95% CI 22.8−28.5), 33.8% (95% CI 37.4−47.4), double resistance clarithromycin-metronidazole 18.9% (95% CI 16.4−21.6), 20.7% (95% CI 17.8−23.8). The increase of the resistance rates to clarithromycin and levofloxacin in naïve patients was statistically significant (<i>p</i> < 0.05). Although eradication rates for sequential therapy in the 10 years considered were 93.4% (95% CI 92−94.6) and 87.5% (95% CI 85.7−89) at per-protocol (PP) and intention-to-treat (ITT) analysis, respectively, they showed a significant decrease in the second five-year period. Conclusions: this data highlights an increase in primary <i>H. pylori</i> antibiotic resistance and strongly suggests the importance of drug susceptibility testing also in naïve patients.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.